BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20811686)

  • 1. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
    Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
    Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.
    Sogabe Y; Suzuki H; Toyota M; Ogi K; Imai T; Nojima M; Sasaki Y; Hiratsuka H; Tokino T
    Int J Oncol; 2008 Jun; 32(6):1253-61. PubMed ID: 18497987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.
    Kim JT; Li J; Jang ER; Gulhati P; Rychahou PG; Napier DL; Wang C; Weiss HL; Lee EY; Anthony L; Townsend CM; Liu C; Evers BM
    Carcinogenesis; 2013 May; 34(5):953-61. PubMed ID: 23354304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma.
    Liu JB; Qiang FL; Dong J; Cai J; Zhou SH; Shi MX; Chen KP; Hu ZB
    World J Gastroenterol; 2011 Nov; 17(44):4917-21. PubMed ID: 22171134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma.
    Saito T; Mitomi H; Imamhasan A; Hayashi T; Mitani K; Takahashi M; Kajiyama Y; Yao T
    Virchows Arch; 2014 Feb; 464(2):135-43. PubMed ID: 24464051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
    Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
    Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.
    Ding Z; Qian YB; Zhu LX; Xiong QR
    World J Gastroenterol; 2009 Jun; 15(21):2595-601. PubMed ID: 19496188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical Wnt pathway gene expression and their clinical correlation in oral squamous cell carcinoma.
    Marimuthu M; Andiappan M; Wahab A; Muthusekhar MR; Balakrishnan A; Shanmugam S
    Indian J Dent Res; 2018; 29(3):291-297. PubMed ID: 29900911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
    Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
    Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
    Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
    Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
    Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.
    Xie J; Zhang Y; Hu X; Lv R; Xiao D; Jiang L; Bao Q
    Med Oncol; 2015 May; 32(5):145. PubMed ID: 25814287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.
    Suzuki H; Toyota M; Carraway H; Gabrielson E; Ohmura T; Fujikane T; Nishikawa N; Sogabe Y; Nojima M; Sonoda T; Mori M; Hirata K; Imai K; Shinomura Y; Baylin SB; Tokino T
    Br J Cancer; 2008 Mar; 98(6):1147-56. PubMed ID: 18283316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methylation Status and mRNA Expression of DKK-3 and WIF-1 in Acute Myeloid Leukemia Patients].
    Xu MM; Yang YL; Geng YH; Li J; Ma Y; Zhang F; Zhu FB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1314-1320. PubMed ID: 29070101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.